Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting.
- DOI
- 10.1111/jdv.16678
- Published
- 2021 Jan
- Container
- Journal of the European Academy of Dermatology and Venereology : JEADV
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jdv.16678,
title = {Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting.},
author = {Krakowski I and Bottai M and Häbel H and Masucci G and Girnita A and Smedby KE and Eriksson H},
year = {2021},
journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
doi = {10.1111/jdv.16678},
url = {https://doi.org/10.1111/jdv.16678}
}RIS
TY - JOUR TI - Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting. AU - Krakowski I AU - Bottai M AU - Häbel H AU - Masucci G AU - Girnita A AU - Smedby KE AU - Eriksson H PY - 2021 JO - Journal of the European Academy of Dermatology and Venereology : JEADV DO - 10.1111/jdv.16678 UR - https://doi.org/10.1111/jdv.16678 ER -
APA
I, K., M, B., H, H., G, M., A, G., KE, S., & H, E. (2021). Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.16678
Source records
- pubmed · retrieved 2026-09-27T16:27:13.929Z